79 related articles for article (PubMed ID: 2140748)
1. [Combination of oral bacterial vaccines and antibiotics in acute recurrent respiratory infections].
Lauriello G; Giella D; Berra A; Matonti V
Clin Ter; 1990 Apr; 133(2):87-90. PubMed ID: 2140748
[TBL] [Abstract][Full Text] [Related]
2. Possibility of interaction among antibiotics and mucolytics in children.
Principi N; Zavattini G; Daniotti S
Int J Clin Pharmacol Res; 1986; 6(5):369-72. PubMed ID: 3781700
[TBL] [Abstract][Full Text] [Related]
3. [The clinical and immunological efficacy of a combination of immunoglobulins and an oral polyvalent antibacterial vaccine in recurrent respiratory infections].
Guerra E; Papetti C; Rosso R; Visconti E; Aiuti F
Clin Ter; 1992 Jan; 140(1):33-41. PubMed ID: 1526096
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience with ambroxol syrup (author's transl)].
Göbel P; Rensch H
Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
[TBL] [Abstract][Full Text] [Related]
5. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
[TBL] [Abstract][Full Text] [Related]
6. [Prophylaxis and treatment of bronchopulmonary complications with ambroxol administered by infusion in elderly patients undergoing surgery].
Bavaro P; Biscari P
G Chir; 1989 Oct; 10(10):605-9. PubMed ID: 2518303
[TBL] [Abstract][Full Text] [Related]
7. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
8. [Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients].
Cegla UH
Prax Klin Pneumol; 1988 Sep; 42(9):715-21. PubMed ID: 3141915
[No Abstract] [Full Text] [Related]
9. Therapeutic activity of ambroxol theophyllinacetate in chronic obstructive pulmonary diseases.
Primbs K
Clin Ther; 1985; 7(6):733-6. PubMed ID: 4075364
[TBL] [Abstract][Full Text] [Related]
10. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
11. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
von der Schulenburg JM; Greiner W; von der Hardt H
Med Klin (Munich); 1995 Apr; 90(4):220-4. PubMed ID: 7776934
[TBL] [Abstract][Full Text] [Related]
12. [Use of a polyvalent oral bacterial vaccine in recurrent respiratory infections in children].
Scotti L; Biondelli G; Borzani M
Minerva Pediatr; 1987 Apr; 39(7):251-6. PubMed ID: 3614148
[No Abstract] [Full Text] [Related]
13. [A case of pulmonary alveolar proteinosis treated with oral administration of ambroxol].
Naito M; Kunieda T; Yoshioka T; Okubo S; Yutani C
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):912-20. PubMed ID: 4079161
[No Abstract] [Full Text] [Related]
14. Antibiotic treatment for urinary tract infections in pediatric patients.
Hellerstein S
Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
[TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.
Roa CC; Dantes RB
Arzneimittelforschung; 1995 Mar; 45(3):267-72. PubMed ID: 7741782
[TBL] [Abstract][Full Text] [Related]
16. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
Romanini BM; Sandri MG; Tosi M; Mezzetti M; Mazzetti A
Int J Clin Pharmacol Res; 1986; 6(2):123-7. PubMed ID: 3522443
[TBL] [Abstract][Full Text] [Related]
17. Steady-state bioavailability and pharmacokinetics of ambroxol and clenbuterol administered alone and combined in a new oral formulation.
Couet W; Girault J; Reigner BG; Ingrand I; Bizouard J; Acerbi D; Chiesi P; Fourtillan JB
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):467-72. PubMed ID: 2807621
[TBL] [Abstract][Full Text] [Related]
18. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
[TBL] [Abstract][Full Text] [Related]
20. [Results of 7 years of prophylactic immunotherapy using a bacterial vaccine in chronic bronchopneumopathies].
Lauriello G; Berra A; Giella D; Matonti V
Clin Ter; 1990 Apr; 133(1):25-9. PubMed ID: 2140741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
